Kewaunee Scientific Corporation
General ticker "KEQU" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $137.8M (TTM average)
Kewaunee Scientific Corporation follows the US Stock Market performance with the rate: 21.9%.
Estimated limits based on current volatility of 2.0%: low 37.58$, high 39.13$
Factors to consider:
- Earnings expected soon, date: 2025-12-10 bmo
- Total employees count: 556 (-7.8%) as of 2024
- US accounted for 67.4% of revenue in the fiscal year ended 2024-04-30
- Top business risk factors: Pandemic risks, Cybersecurity threats, Supply chain disruptions, Market volatility, Manufacturing disruptions
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-04-30 to 2027-04-30
- 2025-04-30 to 2026-04-30 estimated range: [23.45$, 42.01$]
- 2026-04-30 to 2027-04-30 estimated range: [20.63$, 37.51$]
Financial Metrics affecting the KEQU estimates:
- Positive: with PPE of 6.1 at the end of fiscal year the price was neutral
- Positive: -3.60 < Operating profit margin, % of 7.39
- Positive: Operating cash flow per share per price, % of 15.69 > 13.24
- Positive: 18.93 < Shareholder equity ratio, % of 33.11 <= 41.86
- Negative: Inventory ratio change, % of 2.61 > 0.84
- Negative: Industry earnings per price (median), % of 1.68 <= 4.43
- Positive: 5.52 < Industry operating cash flow per share per price (median), % of 9.82
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.62
Short-term KEQU quotes
Long-term KEQU plot with estimates
Financial data
| YTD | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|
| Operating Revenue | $219.49MM | $203.75MM | $240.47MM |
| Operating Expenses | $215.86MM | $185.47MM | $222.71MM |
| Operating Income | $3.63MM | $18.28MM | $17.76MM |
| Non-Operating Income | $0.87MM | $-5.16MM | $-2.97MM |
| Interest Expense | $1.73MM | $1.80MM | $3.21MM |
| R&D Expense | $1.01MM | $0.92MM | $0.00MM |
| Income(Loss) | $4.50MM | $13.12MM | $14.79MM |
| Taxes | $3.14MM | $-5.94MM | $3.20MM |
| Profit(Loss)* | $1.36MM | $18.75MM | $11.40MM |
| Stockholders Equity | $7.08MM | $7.27MM | $64.46MM |
| Inventory | $21.89MM | $20.68MM | $32.85MM |
| Assets | $118.90MM | $134.77MM | $194.65MM |
| Operating Cash Flow | $-3.79MM | $19.56MM | $14.78MM |
| Capital expenditure | $4.15MM | $4.37MM | $2.17MM |
| Investing Cash Flow | $-4.15MM | $-4.37MM | $-30.90MM |
| Financing Cash Flow | $14.93MM | $-3.01MM | $7.41MM |
| Earnings Per Share** | $0.48 | $6.51 | $3.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.